Also known as: Permax (brand); LY-127809; Pergolide free base
Pergolide is a potent ergoline-derived dopamine receptor agonist used in the treatment of Parkinson's disease. Mediocon Inc manufactures this high-purity API at its GMP-certified facility in Aurangabad, Maharashtra, India. Pergolide acts on D1 and D2 dopamine receptor subtypes and was used as adjunctive therapy with levodopa/carbidopa. It is also used in veterinary medicine for the treatment of equine Pituitary Pars Intermedia Dysfunction (PPID/Cushings disease).
| Parameter | Specification |
|---|---|
| CAS Number | 66104-22-1 |
| Molecular Formula | C₁₉H₂₆N₂S |
| Molecular Weight | 314.49 g/mol |
| Grade | IP / BP / EP / USP |
| Category | Dopamine Agonist / Antiparkinsonian |
| Assay | NLT 98.0% |
| Loss on Drying | NMT 0.5% |
| Heavy Metals | NMT 20 ppm |
| Residue on Ignition | NMT 0.1% |
| Microbial Limits | Complies with pharmacopoeia |
| Identification | IR, HPLC Compliant |
| Batch No | PEG/24032026 |
| Mfg Date | MAR 2026 |
| Exp Date | FEB 2031 |
| Packing | 25 kg HDPE drums / as per requirement |
Mediocon Inc is a GMP-certified API manufacturer and bulk pharmaceutical ingredient supplier based in Aurangabad, Maharashtra, India. We specialise in supplying Pergolide — CAS 66104-22-1 (CAS 66104-22-1) and over 1,000 other Active Pharmaceutical Ingredients, excipients, herbal extracts, and nutraceutical ingredients to pharmaceutical manufacturers worldwide.
Our Pergolide — CAS 66104-22-1 is manufactured under strict quality management protocols compliant with WHO-GMP, ISO 9001:2015, and major pharmacopoeial standards (IP, BP, USP, EP). Every batch undergoes full analytical testing — identity (IR/HPLC), assay, related substances, residual solvents (ICH Q3C), heavy metals, and microbial limits — before release with a Certificate of Analysis.
Export Markets
Quality & Compliance